Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lumry

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Mayo Clinic Proceedings|July 13, 2005
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatmentRoger K Cady, David W Dodick, Howard L Levine, et al.
Journal of Clinical Immunology|November 11, 2025
A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary ImmunodeficiencyWilliam R Lumry, Michael Palumbo, Connie Hsu, et al.
Allergy and Asthma Proceedings|March 15, 2013
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation studyWilliam R Lumry, Jonathan A Bernstein, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2016
Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical FacilityIris M Otani, William R Lumry, Shelley Hurwitz, et al.
Journal of Clinical Immunology|February 2, 2026
Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary ImmunodeficiencyWilliam R Lumry, Michael Palumbo, Connie Hsu, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1996
Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitisD I Bernstein, P S Creticos, W W Busse, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJonathan A Bernstein, Michael E Manning, Henry Li, et al.
Clinical and Translational Allergy|September 25, 2023
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstatDanny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 8, 2020
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary AngioedemaPaula J Busse, Sandra C Christiansen, Marc A Riedl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 26, 2019
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized StudyWilliam R Lumry, Inmaculada Martinez-Saguer, William H Yang, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Mayo Clinic Proceedings|July 13, 2005
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatmentRoger K Cady, David W Dodick, Howard L Levine, et al.
Journal of Clinical Immunology|November 11, 2025
A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary ImmunodeficiencyWilliam R Lumry, Michael Palumbo, Connie Hsu, et al.
Allergy and Asthma Proceedings|March 15, 2013
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation studyWilliam R Lumry, Jonathan A Bernstein, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2016
Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical FacilityIris M Otani, William R Lumry, Shelley Hurwitz, et al.
Journal of Clinical Immunology|February 2, 2026
Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary ImmunodeficiencyWilliam R Lumry, Michael Palumbo, Connie Hsu, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1996
Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitisD I Bernstein, P S Creticos, W W Busse, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJonathan A Bernstein, Michael E Manning, Henry Li, et al.
Clinical and Translational Allergy|September 25, 2023
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstatDanny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 8, 2020
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary AngioedemaPaula J Busse, Sandra C Christiansen, Marc A Riedl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 26, 2019
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized StudyWilliam R Lumry, Inmaculada Martinez-Saguer, William H Yang, et al.
Pageof 14